A Comparative Study on Isoflavone Intakes and Blood Lipids between Hypertensive and Normotensive

고혈압 환자와 정상인의 이소플라본 섭취와 혈중 지질상태 비교연구

  • Choi Mi-Kyeong (Department of Human Nutrition & Food Science, Chungwoon University) ;
  • Jun Ye-Sook (Department of Human Nutrition & Food Science, Chungwoon University)
  • 최미경 (청운대학교 식품영양학과) ;
  • 전예숙 (청운대학교 식품영양학과)
  • Published : 2006.04.01

Abstract

It has been suggested that isoflavones protect the cardiovascular system, in part by attenuating blood pressure. The purpose of the present research was to compare the isoflavone intake and blood lipids between hypertensive and normotensive and to examine dietary management for prevention of hypertension. Anthropometrical measurements, blood pressures, nutrients and isoflavone intakes using the 24-hour recall method, and serum lipids of 81 hypertensives and 77 normotensives were estimated. The average age, height, weight, and BMI were 58.2 years, l58.5 cm, 64.3 kg, and $25.6kg/m^2$ for the hypertensive and 58.0 years, 159.4 cm, 63.0 kg, and $24.8kg/m^2$ for the normotensive, respectively. Systolic and diastolic blood pressures of the hypertensive were significantly higher than those of the normotensive (p<0.001, p<0.001). The daily food intake of the hypertensive was significantly lower than that of the normotensive (p<0.01). The daily energy intakes of hypertensive and normotesive were 1479.8 kcal and 1590.9 kcal and there was no significant difference between the two groups. Carbohydrate intake of the hypertensive was significantly higher than that of the normotensive (p<0.05). However, daily intakes of plant protein, fiber, ash, calcium, sodium, potassium, and vitamin $B_1$ of the hypertensive were significantly lower than those of the normotensive (p<0.05, p<0.01, p<0.01, p<0.01, p<0.05, p<0.05, p<0.05). The daily intakes of daidzein, genistein, isoflavone of the hypertensive were significantly lower than those of the normotensive (p<0.05, p<0.05, p<0.05). However, isoflavone intakes per 1000 kcal showed no significant difference between the two groups. Serum lipids of the hypertensive and normotensive were l89.6 mg/dL and l87.2 mg/dL for total cholesterol, 157.3 mg/dL and 161.9 mg/dL for triglyceride, 42.9 mg/dL and 43.5 mg/dL for HDL-cholesterol, 115.2 mg/dL and 111.4 mg/dL for LDL-cholesterol, and 3.5 and 3.4 for atherogenic index. In the total subjects, there was a significantly negative correlation between systolic blood pressure and genistein intake (p<0.05). Based on these results, we concluded that the daily intakes of food, energy, and isoflavones of hypertensives were lower than normotensives. Therefore, it should be emphasized that proper dietary management considering these dietary factors for prevention of hypertension.

Keywords

References

  1. Arkwright PD, Beilin LJ, Rouse I, Armstrong BK, Vandongen R (1982): Effects of alcohol use and other aspects of lifecycle on blood pressure levels and prevalence of hypertension in a working population. Circulation 66: 60-66 https://doi.org/10.1161/01.CIR.66.1.60
  2. Arroll B, Beaglehole R (1992): Does physical activity lower blood pressure: a critical review of the clinical trials. J Clin Epidemiol 45: 439-447 https://doi.org/10.1016/0895-4356(92)90093-3
  3. Chiang BN, Perlman LV, Epstein FH (1969): Overweight and hypertension. A review. Circulation 39: 403-421 https://doi.org/10.1161/01.CIR.39.3.403
  4. Choi MK, Kim MH, Sung CJ, Lee WY, Park JD (2005): A study on relation among habitual isoflavone intake, blood pressure, and serum lipid parameters in Korean men and women over 20 years old. Korean J Community Nutr 10(4): 493-500
  5. de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, Jacques PF (2001): Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study (1-4). J Nutr 131(6): 1826-1832
  6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001): Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adults treatment III). JAMA 285: 2486-2497 https://doi.org/10.1001/jama.285.19.2486
  7. Ford ES, Giles WH, Dietz WH (2002): Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356-359 https://doi.org/10.1001/jama.287.3.356
  8. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, Custer LJ (1999): Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 47(3): 977-986 https://doi.org/10.1021/jf9808832
  9. Friedewald WY, Levy RI, Fredrickson DS (1972): Estimation of concentration of low-density lipoprotein cholesterol on plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
  10. Guidelines Committee (2003): European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 21: 1011-1053 https://doi.org/10.1097/00004872-200306000-00001
  11. Guidelines Sub-Committee (1999): World Health Organization- International Society of Hypertension guidelines for the management of hypertension. J Hypertension 17:151-183
  12. Iso H, Terao A, Kitamura A, Sato S, Naito Y, Kiyama M, Tanigaki M, Iida M, Konishi M, Shimamoto T, Komachi Y (1991): Calcium intake and blood pressure in seven Japanese populations. Am J Epidemiol 133(8): 776-783 https://doi.org/10.1093/oxfordjournals.aje.a115956
  13. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG (2002): Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76(2): 365-372 https://doi.org/10.1093/ajcn/76.2.365
  14. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2003): The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 289: 2560-2572 https://doi.org/10.1001/jama.289.19.2560
  15. Kannel WB (2000): Incidence and epidemiology of heart failure. Heart Fail Rev 5(2): 167-173 https://doi.org/10.1023/A:1009884820941
  16. Kim BS (2002): Prevalence of metabolic syndrome for Koreans-Among the clients of comprehensive medical examination center in one university hospital. Kor J Diabetes Assoc 26(5): 431-442
  17. Kruck F, Glanzer K, Sarger M, Overlack A (1984): Effects of potassium on blood pressure regulation. J Cardiovasc Pharmacol 6S: 224-229
  18. Lee SK, Yoon S, Lee MJ, Kwon DJ (2000): Estimated isoflavone intake from soy products in Korean middle-aged women. J Korean Soc Food Sci Nutr 29(5): 948-956
  19. Li HF, Wang LD, Qu SY (2004): Phytoestrogen genistein decreases contractile response of aortic artery in vitro and arterial blood pressure in vivo. Acta Pharmacol Sin 25(3): 313-318
  20. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000): Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11(6): 326-331 https://doi.org/10.1016/S0955-2863(00)00085-1
  21. Maki KC (2004): Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. Am J Cardiol 93: 12C-17C https://doi.org/10.1016/j.amjcard.2004.02.001
  22. Ministry of Health and Welfare (2002): Report on 2001 national health and nutrition survey. Ministry of Health and Welfare, Seoul
  23. Moore TJ (1989): The role of dietary electrolyte in hypertension. Am J Coll Nutr 8S: 68-80
  24. Mujais SK, Tarazi RC, Dustan HP, Fouad FM, Bravo EL (1982): Hypertension in obese patients: hemodynamics & volume studies. Hypertension 4(1): 84-92 https://doi.org/10.1161/01.HYP.4.1.84
  25. Nevala R, Vaskonen T, Vehniainen J, Korpela R, Vapaatalo H (2000): Soy based diet attenuates the development of hypertension when compared to casein based diet in spontaneously hypertensive rat. Life Sci 66(2): 115-124 https://doi.org/10.1016/S0024-3205(99)00569-X
  26. Rivas M, Garay RP, Escanero JF, Cia P Jr, Cia P, Alda JO (2002): Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132(7): 1900-1902 https://doi.org/10.1093/jn/132.7.1900
  27. Reusser ME, McCarron DA (1994): Micronutrient effects on blood regulation. Nutr Rev 52(11): 367-375 https://doi.org/10.1111/j.1753-4887.1994.tb01367.x
  28. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M (2006): Soy protein, isoflavones, and cardiovascular health. An American heart association science advisory for professionals from the nutrition committee. Circulation 17: 1-11
  29. World Health Organization (1998): Obesity. Preventing and managing the global epidemic. WHO, Genova
  30. Yang JL, Lee SH, Song YS (2003): Improving effect of powders of cooked soybean and Chongkukjang on blood pressure and lipid metabolism in spontaneously hypertensive rats. J Korean Soc Food Sci Nutr 32(6): 899-905 https://doi.org/10.3746/jkfn.2003.32.6.899
  31. Yu R, Park SA, Chung DK, Nam HS, Shin ZI (1996): Effect of soybean hydrolysate on hypertension in spontaneously hypertensive rats. J Korean Soc Food Sci Nutr 25(6): 1031-1036
  32. 고혈압진료지침제정위원회(2004): 고혈압치료의 진단기준 및 치료목표. 대한고혈압학회, 서울